Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis. - Wikidata - awgldk - TriplyDB

Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis.

Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis.

http://www.wikidata.org/entity/Q55005053

about

Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis.Microvascular invasion in hepatocellular carcinoma.Correlation of postoperative recurrence in hepatocellular carcinoma with demethylation of repetitive sequences.Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma.Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma.Prognostic effects of causative virus in hepatocellular carcinoma according to the Japan integrated staging (JIS) score.Correlation of clinicopathologic features of resected hepatocellular carcinoma with hepatitis C virus genotype.Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis.The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus-related hepatocellular carcinoma.Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.Prevention of cancer recurrence after treatment for hepatitis C virus-related hepatocellular carcinoma by interferon therapy.Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy.Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma.A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA.Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C.Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.

P2860

Q24234212-67C3EA15-5DC5-4CB5-ABCC-B650A3C3FE96 Q24236020-E85D7675-6DA9-43AB-B9CE-A5511113452D Q26829868-1C8B9132-DD6E-4258-8D16-070EC9F803DF Q28392783-5D27FA48-54BC-4F7E-8A1E-33EE4DAD6CE6 Q28394414-FE47BC24-1533-4A45-B87F-54C507D3187F Q33920626-57C7696D-1F4C-4BA7-B28F-554816503606 Q36682732-81A7F89E-727F-4483-B740-35235FB3B1BB Q40659385-D2D5A67E-7D10-4291-88BE-59D93203625F Q42991471-2F7BD76C-B6A8-4B67-AAA3-977D0FDC86F4 Q42994894-103C5775-BB1B-4DF9-A7F9-6C3E8B438EF3 Q42996364-AFAA3C68-E428-4A7E-8050-331331070BF1 Q42997162-60E92B3F-43A7-4744-937D-4C5843F90216 Q43037255-85A7CC0E-22F9-41D1-98D6-AE934CFFF866 Q43828352-056E5109-D7E8-426E-93E5-9D3E8747CC78 Q44037864-D1A47045-0218-48D6-B71C-F01C8FA2A560 Q45341300-F90EA492-5D6B-4A36-8B4F-63A119A7E30C Q45732900-D3C8F134-9D85-47C6-922F-DD179727BDD7 Q45744078-66F33B97-31EF-45DE-BDB2-C9FFA8766E95 Q53411281-5403E23E-3BBC-45DA-9F71-5C24D9532396 Q53416052-077A6426-CA7B-4888-9DC4-3A921AA543FA Q55094662-6134FFE6-B011-4E41-A9C1-432808491BE6

P2860

Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis.

http://www.wikidata.org/entity/Q55005053

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh

1998年學術文章

@zh-hant

name

Clinicopathological criteria f ...... ctors for such carcinogenesis.

@en

Clinicopathological criteria f ...... ctors for such carcinogenesis.

@nl

type

label

Clinicopathological criteria f ...... ctors for such carcinogenesis.

@en

Clinicopathological criteria f ...... ctors for such carcinogenesis.

@nl

prefLabel

Clinicopathological criteria f ...... ctors for such carcinogenesis.

@en

Clinicopathological criteria f ...... ctors for such carcinogenesis.

@nl

P1433

Q55005053-7519166B-914D-4710-B6A5-520024D8D1CB

P1476

Q55005053-F0B6079E-49FB-45B1-876C-DE17C3A7A7AF

P2093

Q55005053-18BACA69-4985-4D7F-8381-FD9ECC35F1D7

Q55005053-1E55F525-04E1-47D6-BC56-21C71A4C361D

Q55005053-3DD10817-80DA-4284-97DB-FF0F25EDA9FA

Q55005053-45437714-95C5-429C-8E68-C94B230139E7

Q55005053-9135A854-8F03-4210-80F9-3AD4EF11D12B

Q55005053-9EB12DE4-AA95-4BC3-AE16-6257EF2DEE65

Q55005053-A50933A6-3294-48D2-8688-9DBC4BCE0520

Q55005053-AAAFF179-D6D1-4D8E-B9EF-52A0459FA635

Q55005053-BD9ADBE5-DBF9-41A8-8523-B2ACF8EBE452

Q55005053-F4BD8562-6D3B-4FA7-A2E6-C0505CD108A2

P2860

Q55005053-0D540CEE-C6BB-42FC-9844-9ED13B800E22

Q55005053-0E0F05BD-CE9D-4D26-8BC1-3D5313A113CF

Q55005053-1C3A1110-32AA-4A1C-B638-83C650B2A523

Q55005053-2BC06C10-EC86-432D-BB4E-C5EA1D961226

Q55005053-2FC257A1-DB0F-4667-B4D3-8D1EF61E6AEA

Q55005053-3A7B1230-A796-4C94-844C-9898A74D8C10

Q55005053-3ACBA3BA-EDA2-4738-911C-8BEBA3855470

Q55005053-3B44A618-5021-493F-96B3-4E48AF9925E0

Q55005053-42DF2020-A90B-4532-96BC-119C5B97941D

Q55005053-4E00E136-AE3F-41B0-B823-93017DC030C2

P304

Q55005053-294CBE9D-9897-4CAF-80F5-2BA27BEBF364

P31

Q55005053-DDDD2B0E-8B34-4017-B945-4A5CCFE9A7BE

P356

Q55005053-04185911-940B-4FA9-BA3E-CA11A006D1EB

P433

Q55005053-DA98101E-22C9-4BEB-8D2F-913B41D4B9D8

P478

Q55005053-FCA8695F-5409-415A-9559-0A2C988EF1BA

P577

Q55005053-64101DF6-6DAA-4517-97F1-A77FB9FFD61E

P5875

Q55005053-8FA1D76B-9F96-4BDA-A4B7-C8C875DD48C4

P698

Q55005053-0330EBB0-806B-431F-8D9F-F6E6B1F8D19F

P932

Q55005053-C0D3E15A-E074-4A74-B091-DD8C8C01696D

P356

J.1349-7006.1998.TB00580.X

P1433

Japanese Journal of Cancer Research

P1476

Clinicopathological criteria f ...... ctors for such carcinogenesis.

@en

P2093

H Kinoshita

http://www.w3.org/2001/XMLSchema#string

K Hirohashi

http://www.w3.org/2001/XMLSchema#string

K Wakasa

http://www.w3.org/2001/XMLSchema#string

S Kubo

http://www.w3.org/2001/XMLSchema#string

S Minamitani

http://www.w3.org/2001/XMLSchema#string

S Nishiguchi

http://www.w3.org/2001/XMLSchema#string

T Ikebe

http://www.w3.org/2001/XMLSchema#string

T Kuroki

http://www.w3.org/2001/XMLSchema#string

T Shuto

http://www.w3.org/2001/XMLSchema#string

T Yamamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma

Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma.

Viruses and hepatocellular carcinoma.

Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma.

Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA

Pathology of small hepatocellular carcinoma. A proposal for a new gross classification.

Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors.

Classification of chronic hepatitis: diagnosis, grading and staging.

Biochemistry and functions of hepatitis B virus X protein.

Insertional activation of mevalonate kinase by hepatitis B virus DNA in a human hepatoma cell line.

P304

419-426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.1998.TB00580.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

1998-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13667714

http://www.w3.org/2001/XMLSchema#string

P698

9617348

http://www.w3.org/2001/XMLSchema#string

P932

5921811

http://www.w3.org/2001/XMLSchema#string